Skip to main content
Top
Published in: Supportive Care in Cancer 2/2008

01-02-2008 | Original Article

The influence of xerostomia after radiotherapy on quality of life

Results of a questionnaire in head and neck cancer

Authors: Piet Dirix, Sandra Nuyts, Vincent Vander Poorten, Pierre Delaere, Walter Van den Bogaert

Published in: Supportive Care in Cancer | Issue 2/2008

Login to get access

Abstract

Introduction

Xerostomia is a common complication of radiotherapy for head and neck cancer because irreparable damage is caused to the salivary glands if they are included in the radiation fields. The aim of the study was to evaluate the degree of xerostomia in survivors of head and neck cancer and to determine its impact on quality of life.

Methods and materials

A xerostomia questionnaire consisting of three parts (xerostomia score, quality of life survey, and visual analogue scale) was completed by 75 head and neck cancer patients, more than 6 months after radiotherapy and without evidence of disease.

Results

The majority of patients (93%) suffered from a dry mouth, and 65% had moderate to severe xerostomia (grade 2 to 3). Both dysphagia (65%) and taste loss (63%) were common, although oral pain was less frequent (33%). The emotional impact of xerostomia was significant, causing worry (64%), tension (61%), or feelings of depression (44%). Furthermore, patients reported problems with talking to (60%) or eating with (54%) other people and to feel restricted in amount and type of food (65%). Quality of life was influenced by T classification, clinical stage, a higher radiation dose or the use of concomitant chemotherapy, but was independent of the interval since the end of radiotherapy.

Conclusions

Xerostomia after radiotherapy for head and neck cancer is extremely common and significantly affects quality of life. No recuperation is seen over time, and the use of concomitant chemotherapy significantly increases the oral complications of radiation. These results warrant the continuing efforts put into the development of salivary gland-sparing radiotherapy techniques and effective treatments of radiation-induced xerostomia.
Literature
1.
go back to reference Bjordal K, Kaasa S, Mastekaasa A (1994) Quality of life in patients treated for head and neck cancer. Int J Radiat Oncol Biol Phys 28:847–856PubMed Bjordal K, Kaasa S, Mastekaasa A (1994) Quality of life in patients treated for head and neck cancer. Int J Radiat Oncol Biol Phys 28:847–856PubMed
2.
go back to reference Bjordal K, Freng A, Thorvik J, Kaasa S (1995) Patient self-reported and clinician-rated quality of life in head and neck cancer patients: a cross-sectional study. Oral Oncol 31:235–241 Bjordal K, Freng A, Thorvik J, Kaasa S (1995) Patient self-reported and clinician-rated quality of life in head and neck cancer patients: a cross-sectional study. Oral Oncol 31:235–241
3.
go back to reference Braam PM, Roesink JM, Moerland MA et al (2005) Long-term parotid gland function after radiotherapy. Int J Radiat Oncol Biol Phys 62:659–664PubMedCrossRef Braam PM, Roesink JM, Moerland MA et al (2005) Long-term parotid gland function after radiotherapy. Int J Radiat Oncol Biol Phys 62:659–664PubMedCrossRef
4.
go back to reference Braam PM, Roesink JM, Raaijmakers C, Busschers W, Terhaard C (2007) Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy. Radiat Oncol 2:3PubMedCrossRef Braam PM, Roesink JM, Raaijmakers C, Busschers W, Terhaard C (2007) Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy. Radiat Oncol 2:3PubMedCrossRef
5.
go back to reference Bussels B, Maes A, Flamen P et al (2004) Dose–response relationships within the parotid gland after radiotherapy for head and neck cancer. Radiother Oncol 73:297–306PubMedCrossRef Bussels B, Maes A, Flamen P et al (2004) Dose–response relationships within the parotid gland after radiotherapy for head and neck cancer. Radiother Oncol 73:297–306PubMedCrossRef
6.
go back to reference Dirix P, Nuyts S, Van den Bogaert W (2006) Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer 107(11):2525–2534PubMedCrossRef Dirix P, Nuyts S, Van den Bogaert W (2006) Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer 107(11):2525–2534PubMedCrossRef
7.
go back to reference Dirix P, Nuyts S, Vander Poorten V, Van den Bogaert W (2007) Efficacy of the BioXtra dry mouth care system in the treatment of radiotherapy-induced xerostomia. Support Care Cancer (in press; E-pub ahead of print) Dirix P, Nuyts S, Vander Poorten V, Van den Bogaert W (2007) Efficacy of the BioXtra dry mouth care system in the treatment of radiotherapy-induced xerostomia. Support Care Cancer (in press; E-pub ahead of print)
8.
go back to reference Duncan GG, Epstein JB, Tu D, El Sayed S, Bezjak A, Ottaway J, Pater J (2005) Quality of life, mucositis and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucostis. Head Neck 27:421–428PubMedCrossRef Duncan GG, Epstein JB, Tu D, El Sayed S, Bezjak A, Ottaway J, Pater J (2005) Quality of life, mucositis and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucostis. Head Neck 27:421–428PubMedCrossRef
9.
go back to reference Eisbruch A, Rhodus N, Rosenthal D et al (2003) How should we measure and report radiotherapy-induced xerostomia? Semin Radiat Oncol 13:226–234PubMedCrossRef Eisbruch A, Rhodus N, Rosenthal D et al (2003) How should we measure and report radiotherapy-induced xerostomia? Semin Radiat Oncol 13:226–234PubMedCrossRef
11.
go back to reference Epstein JB, Emerton S, Kolbinson DA et al (1999) Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 21:1–11PubMedCrossRef Epstein JB, Emerton S, Kolbinson DA et al (1999) Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 21:1–11PubMedCrossRef
12.
go back to reference Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P (2001) Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 23:389–398PubMedCrossRef Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P (2001) Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 23:389–398PubMedCrossRef
13.
go back to reference Guchelaar H, Vermes A, Meerwaldt JH (1997) Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment. Support Care Cancer 5:281–288PubMedCrossRef Guchelaar H, Vermes A, Meerwaldt JH (1997) Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment. Support Care Cancer 5:281–288PubMedCrossRef
14.
go back to reference Harrison L, Zelefski M, Pfitzer D et al (1997) Detailed quality of life assessment in patients treated with primary radiotherapy for cancer of the base of tongue. Head Neck 19:169–175PubMedCrossRef Harrison L, Zelefski M, Pfitzer D et al (1997) Detailed quality of life assessment in patients treated with primary radiotherapy for cancer of the base of tongue. Head Neck 19:169–175PubMedCrossRef
15.
go back to reference Hassan SJ, Weymuller EA (1993) Assessment of quality of life in head and neck cancer patients. Head Neck 15:485–496PubMedCrossRef Hassan SJ, Weymuller EA (1993) Assessment of quality of life in head and neck cancer patients. Head Neck 15:485–496PubMedCrossRef
16.
go back to reference Henk JM (1997) Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity. Clin Oncol 9:308–312CrossRef Henk JM (1997) Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity. Clin Oncol 9:308–312CrossRef
17.
go back to reference Hoopman R, Muller MJ, Terwee CB, Aaronson NK (2006) Translation and validation of the EORTC QLQ-C30 for use among Turkish and Moroccan ethnic minority cancer patients in the Netherlands. Eur J Cancer 42(12):1839–1847PubMedCrossRef Hoopman R, Muller MJ, Terwee CB, Aaronson NK (2006) Translation and validation of the EORTC QLQ-C30 for use among Turkish and Moroccan ethnic minority cancer patients in the Netherlands. Eur J Cancer 42(12):1839–1847PubMedCrossRef
18.
19.
go back to reference Long SA, D’Antonio LL, Robinson EB, Zimmerman G, Petti G, Chonkich G (1996) Factors related to quality of life and functional status in 50 patients with head and neck cancer. Laryngoscope 106:1084–1088PubMedCrossRef Long SA, D’Antonio LL, Robinson EB, Zimmerman G, Petti G, Chonkich G (1996) Factors related to quality of life and functional status in 50 patients with head and neck cancer. Laryngoscope 106:1084–1088PubMedCrossRef
20.
go back to reference Maes A, Weltens C, Flamen P et al (2002) Preservation of parotid function with uncomplicated conformal radiotherapy. Radiother Oncol 63:203–211PubMedCrossRef Maes A, Weltens C, Flamen P et al (2002) Preservation of parotid function with uncomplicated conformal radiotherapy. Radiother Oncol 63:203–211PubMedCrossRef
21.
go back to reference Meirovitz A, Murdoch-Kinch CA, Schipper M, Pan C, Eisbruch A (2006) Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys 66(2):445–453PubMed Meirovitz A, Murdoch-Kinch CA, Schipper M, Pan C, Eisbruch A (2006) Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys 66(2):445–453PubMed
22.
go back to reference Meyer TK, Kuhn JC, Campbell BH et al (2004) Speech intelligibility and quality of life in head and neck survivors. Laryngoscope 114:1977–1981PubMedCrossRef Meyer TK, Kuhn JC, Campbell BH et al (2004) Speech intelligibility and quality of life in head and neck survivors. Laryngoscope 114:1977–1981PubMedCrossRef
23.
go back to reference Nieuw Amerongen AV, Veerman ECI (2003) Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 11:226–231PubMed Nieuw Amerongen AV, Veerman ECI (2003) Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 11:226–231PubMed
24.
go back to reference Roesink J, Schipper M, Busschers W, Raaijmakers C, Terhaard C (2005) A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: implications for future trials. Int J Radiat Oncol Biol Phys 63:1006–1009PubMedCrossRef Roesink J, Schipper M, Busschers W, Raaijmakers C, Terhaard C (2005) A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: implications for future trials. Int J Radiat Oncol Biol Phys 63:1006–1009PubMedCrossRef
25.
go back to reference Thoeny H, De Keyzer F, Claus F, Sunaert S, Hermans R (2005) Gustatory stimulation changes the apparent diffusion coefficient of salivary glands: initial experience. Radiology 235:629–634PubMedCrossRef Thoeny H, De Keyzer F, Claus F, Sunaert S, Hermans R (2005) Gustatory stimulation changes the apparent diffusion coefficient of salivary glands: initial experience. Radiology 235:629–634PubMedCrossRef
26.
go back to reference Van Acker F, Flamen P, Lambin P et al (2001) The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapy. Nucl Med Common 22:225–231CrossRef Van Acker F, Flamen P, Lambin P et al (2001) The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapy. Nucl Med Common 22:225–231CrossRef
27.
go back to reference Weymuller EA, Yueh B, Deleyiannis F et al (2000) Quality of life in head and neck cancer. Laryngoscope 110(Suppl 94):4–7PubMedCrossRef Weymuller EA, Yueh B, Deleyiannis F et al (2000) Quality of life in head and neck cancer. Laryngoscope 110(Suppl 94):4–7PubMedCrossRef
28.
go back to reference Weymuller EA, Yueh B, Deleyiannis F et al (2000) Quality of life in patients with head and neck cancer. Lessons learned from 549 prospectively evaluated patients. Arch Otolaryngol Head Neck Surg 126:329–335PubMed Weymuller EA, Yueh B, Deleyiannis F et al (2000) Quality of life in patients with head and neck cancer. Lessons learned from 549 prospectively evaluated patients. Arch Otolaryngol Head Neck Surg 126:329–335PubMed
29.
go back to reference Wijers O, Levendag P, Braaksma M, Boonzaaijer M, Visch L, Schmitz P (2002) Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors. Head Neck 24:737–747PubMedCrossRef Wijers O, Levendag P, Braaksma M, Boonzaaijer M, Visch L, Schmitz P (2002) Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors. Head Neck 24:737–747PubMedCrossRef
Metadata
Title
The influence of xerostomia after radiotherapy on quality of life
Results of a questionnaire in head and neck cancer
Authors
Piet Dirix
Sandra Nuyts
Vincent Vander Poorten
Pierre Delaere
Walter Van den Bogaert
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 2/2008
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0300-5

Other articles of this Issue 2/2008

Supportive Care in Cancer 2/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine